Thyroid hormone (T 3 ) influences cell proliferation, death and differentiation during development of the central nervous system (CNS). Hormone action is mediated by T 3 receptors (TR) of which there are two subtypes, TRα and TRβ. Specific roles for TR subtypes in CNS development are poorly understood. We analyzed involvement of TRα and TRβ in neural cell proliferation during metamorphosis of Xenopus laevis. Cell proliferation in the ventricular/subventricular neurogenic zones of the tadpole brain increased dramatically during metamorphosis. This increase was dependent on T 3 until mid-prometamorphosis, after which cell proliferation decreased and became refractory to T 3 . Using double labeling fluorescent histochemistry with confocal microscopy we found TRα expressed throughout the tadpole brain, with strongest expression in proliferating cells. By contrast, TRβ was expressed predominantly outside of neurogenic zones. To corroborate the histochemical results we transfected living tadpole brain with a Xenopus TRβ promoter-EGFP plasmid and found that most EGFP expressing cells were not dividing. Lastly, treatment with the TRα selective agonist CO23 increased brain cell proliferation; whereas, treatment with the TRβ-selective agonists GC1 or GC24 did not. Our findings support the view that T 3 acts to induce cell proliferation in the tadpole brain predominantly, if not exclusively, via TRα.
Introduction
Thyroid hormone (T 3 ) plays a critical role in postembryonic maturation of the vertebrate brain. In mammals, T 3 has been shown to influence dendritic branching, axonal density, synapse number, myelination, and cell proliferation (Oppenheimer and Schwartz, 1997; Porterfield and Hendrich, 1993) . The lack of TH during fetal and neonatal life results in a condition of severe mental retardation known as cretinism (Legrand, 1982; Porterfield and Hendrich, 1993) . Disruption of T 3 signaling in the fetus or neonate by environmental chemicals can result in impaired neurological development (Porterfield, 1994; Zoeller, 2005) .
Thyroid hormone acts by binding to ligand-activated transcription factors (thyroid hormone receptors; TR) and regulating gene transcription (Nunez et al., 2008) . In all jawed vertebrates that have been studied there are two paralogous genes that code for TRs, designated TRα and TRβ (reviewed by Furlow and Neff, 2006) . In mammals, several functional TR isoforms resulting from differential mRNA processing have been identified (TRα1, TRβ1, TRβ2, TRβ3). The TRα2 isoform does not bind ligand, may function as a dominant negative transcriptional repressor, and is highly expressed throughout the developing rodent brain (Bradley et al., 1992) . The cell type and developmental stage-specific expression of TR genes suggest that the protein products subserve different functions in brain development (Nunez et al., 2008) .
The amphibian tadpole is an important model system for investigating the molecular basis for T 3 action in development. Thyroid hormone is required for tadpole metamorphosis, during which time the brain undergoes morphological and biochemical changes that prepare the animal for adult life (Denver, 1998) . Metamorphosis often involves a habitat shift from an aquatic to a terrestrial environment, and the adult frog exhibits dramatically different behaviors and other life history characteristics compared with the tadpole (Denver et al., 2002) . This process requires the creation, modification or elimination of many structures. For example, the Mauthner neurons found on either side of the medulla and the sensory and motoneurons supplying the tail are lost (reviewed by Denver, 1998) . Conversely, new structures such as the major portion of the retina arises, along with associated ipsilateral visual projections in the diencephalon and mesencephalon (Hoskins, 1990) . The cerebellum undergoes expansion and the neurosecretory neurons in the diencephalon and their projections to the median eminence develop. Thyroid hormone is critical for all of these changes (reviewed by Denver, 1998) . Earlier studies using classical histochemical staining showed that thyroid hormone treatment increased apparent mitotic activity in different regions of the central nervous system (CNS) of several amphibian species (Chibon and Dournon, 1974; Weiss and Rossetti, 1951a; Weiss and Rossetti, 1951b) . Each of these studies focused on specific brain regions, and there has not been a systematic analysis of developmental changes or effects of exogenous T 3 on cell proliferation throughout the CNS of an amphibian during metamorphosis.
Xenopus laevis has four TR genes, two TRα and two TRβ (designated A or B) owing to its pseudotetraploidy . In tadpoles the TRα is expressed shortly after hatching and remains at a relatively constant level throughout tadpole development and metamorphosis, increasing slightly during late prometamorphosis (Kawahara et al., 1991; . By contrast, the TRβ is expressed at a very low level in the tadpole but increases dramatically during prometamorphosis coincident with rising plasma T 3 concentrations. Several lines of evidence support a role for TRα in establishing tissue competence to respond to T 3 , and in the proliferative actions of the hormone, particularly in the hindlimbs. Whereas, the expression pattern of TRβ, which is dependent on the rise in plasma T 3 during metamorphosis, and findings using the TRβ specific T 3 analog GC1 support the view that TRβ functions in cell differentiation and apoptosis (reviewed by Furlow and Neff, 2006) .
In the present study we analyzed cell proliferation in the tadpole CNS and the involvement of specific TR subtypes in this process. We determined the developmental schedule and thyroid dependence of cell proliferation in ventricular/subventricular neurogenic zones (VZ/ SVZ) throughout the tadpole brain during metamorphosis. We used histochemistry to localize TRα and TRβ expression, and proliferating cells in the tadpole brain. Using electroporation-mediated gene transfer into the brain of living tadpoles, we asked whether the TRβ gene promoter is activated in proliferating cells. Lastly, we treated tadpoles with TR subtype-specific agonists and analyzed brain cell proliferation to determine which TR subtype mediates the neurogenic actions of T 3 during metamorphosis of X. laevis.
Materials and methods

Animals and animal husbandry
Xenopus laevis tadpoles (obtained from Xenopus One, Dexter, MI) were raised in dechlorinated tap water (water temperature, 21-22°C) and fed pulverized rabbit chow ad libitum. Developmental stages were assigned according to Nieuwkoop and Faber (1994) and general staging criteria of Etkin (1968) where premetamorphosis is the stage of tadpole development when the animal grows but little or no morphological change occurs and plasma thyroid hormone concentrations are low; prometamorphosis is the stage when metamorphosis begins, hindlimb growth accelerates and the thyroid gland becomes active and secretes thyroid hormone in response to increasing plasma concentrations of pituitary thyroid stimulating hormone; and metamorphic climax is the final and most rapid phase of morphological change when thyroid activity is at its peak. Thyroid hormone (3,5,3′-L-triiodothyronine; T 3 sodium salt; final concentration 10 or 50 nM; Sigma-Aldrich, St. Louis, MO) or bromodeoxyuridine (BrdU; final concentration 500 μM Sigma-Aldrich) were added to the aquarium water, and the water was changed and hormone replenished daily over the treatment period (3-48 h; see below). The goitrogen methimazole (MMI; Sigma-Aldrich) was added to the aquarium water to a final concentration of 1 mM and treatment continued for 7 days (see Denver et al., 1997) . At the termination of each experiment tadpoles were euthanized by immersion in 0.1% benzocaine and brains harvested for histochemistry.
Experimental design for cell proliferation studies
The experimental paradigms for BrdU labeling and T 3 treatment are depicted graphically in Fig. 1 .
Experiment 1
We first analyzed the effect of T 3 on cell proliferation throughout the brain of premetamorphic X. laevis tadpoles (NF stage 52). Tadpoles were immersed in BrdU with or without T 3 (50 nM) for 48 h (n = 5/treatment). We sectioned brains sagittally and analyzed BrdU incorporation by immunohistochemistry (IHC; see below).
Experiment 2
We next conducted an experiment to determine whether T 3 treatment 1) caused a shortening of the cell cycle time, or 2) recruited stem cells that were not dividing to enter mitosis. The experiment involved a 'pulse-chase' design. Early prometamorphic tadpoles (NF stage 54) were immersed in BrdU for 7 h ('pulse'). They were then transferred to fresh water without BrdU for 24 h ('chase'; to clear the BrdU), then treated with or without T 3 (50 nM) for 24 or 48 h (n = 6-12/treatment).
Experiment 3
We examined developmental stage-dependent changes in brain cell proliferation in tadpoles undergoing spontaneous metamorphosis, and we determined if the effects of T 3 on cell proliferation are stage-dependent. Tadpoles at different developmental stages (54) (55) (56) (57) (58) (59) (60) (61) (62) (63) were treated with or without T 3 (50 nM) for 48 h followed by immersion in BrdU (T 3 still present) for 3 h before sacrifice (n = 6-12/group). Brains were collected and processed for fluorescent IHC for BrdU, in situ hybridization histochemistry (ISHH) for TRα or TRβ mRNAs, dual fluorescent IHC for BrdU and ISHH for TRα mRNA, or dual fluorescent IHC for BrdU and TRβ protein (described below).
Experiment 4
We tested whether the increase in endogenous thyroid hormone during metamorphosis accounts for the increase in brain cell proliferation by blocking thyroid hormone synthesis with MMI. Prometamorphic tadpoles (NF stage 56) were chosen for this study since thyroid hormone synthesis and secretion rises at this stage of development (Krain and Denver, 2004; Leloup and Buscaglia, 1977; Tata, 1993) and there is a high rate of cell proliferation throughout the brain (see Results). Tadpoles were treated with or without 1 mM MMI for 5 days. The MMI-treated group was then divided into two groups, one with and one without T 3 (10 nM) and the treatments were continued for 2 more days. Thus, there were three treatment groups at the end of the experiment: vehicle-treated controls, MMI, and MMI + T 3 . Brains (n = 5/treatment) were collected and processed for IHC for BrdU or phosphorylated histone 3 (pH3; see below).
Experimental design for thyroid hormone analog experiments
We used three different thyroid hormone analogs that are selective agonists for TRα or TRβ to test for effects on tadpole brain cell proliferation. GC1 and GC24 are selective agonists for TRβ. GC1 binds to TRβ with an affinity 5-7 times greater than for TRα, but shows 10-100-fold greater selectivity for TRβ vs. TRα in transfection assays (Chiellini et al., 1998; Furlow et al., 2004) . GC24 is more specific, exhibiting 40-60 greater selectivity for TRβ than GC1 (Borngraeber et al., 2003) . Both GC1 and GC24 exhibit affinities for TRβ in binding assays, or potencies in transfection assays that are comparable to or greater than those observed for the native ligand T 3 (Chiellini et al., 1998; Furlow et al., 2004; Borngraeber et al., 2003) . CO23 is a TRα selective agonist which, although it has similar affinity for TRα and TRβ when tested in in vitro binding assays, shows 5-10 times greater potency in cell-based transactivation assays for TRα compared with TRβ (Ocasio and Scanlan, 2006) . In these assays CO23 exhibited approximately 10 times lower potency than T 3 . The TRα selectivity of CO23 is further supported by its activity in the Xenopus tadpole metamorphosis assay, where it caused significant growth of the hindlimbs, considered to be a TRα-dependent process, but was much less potent in causing tail or gill resorption, or cranial restructuring, two processes thought to be dependent on TRβ (Ocasio and Scanlan, 2006) . We dissolved the T 3 and the analogs in dimethylsulfoxide (DMSO); controls were treated with DMSO only, and all treatments received DMSO to a final concentration of 0.001% in the aquarium water. We added the compounds directly to the aquarium water and changed the water and replenished the compounds at 24 h.
We treated premetamorphic tadpoles (NF stage 52) with vehicle, T 3 , GC1, GC24 or CO23 for 48 h before sacrifice and IHC analysis for pH3 in the brain (n = 4/treatment). The compounds were added to the aquarium water to a final concentration of 10 nM for T 3 , and 100 nM for the thyroid hormone analogs. We continued treating six animals in each group for an additional 4 days to assess effects on external metamorphic changes. The T 3 treated animals showed dramatic metamorphic changes by 3 days and all died by day 4 of treatment. The goal was to verify the bioactivity of the GC compounds by following external morphological changes; Furlow et al. (2004) showed that doses of GC1 at 50 nM or above caused gill and tail resorption, but had little or no effect on limb growth except at the highest concentration tested (N200 nM).
Thyroid hormone receptor riboprobes and TR antisera
We made subtype-specific riboprobes for X. laevis TRs by generating partial cDNAs by PCR. PCR fragments of TRα (spanning amino acids 122-384) and TRβ (spanning amino acids 245-521) were subcloned into the pGEM-T easy vector following the manufacturer's instructions (Promega). The orientation and sequence of the cloned products were verified by direct DNA sequencing. Linearized plasmids were used for riboprobe synthesis (see below).
We used a rabbit anti-X. laevis TRα (xTRα) polyclonal serum (gift of Yun-Bo Shi; #94114) that was raised against two synthetic peptides corresponding to amino acids 1-18 and 15-34 of the xTRα protein coupled to keyhole limpet hemocyanin. A rabbit anti-X. laevis TRβ (xTRβ) polyclonal serum (a gift of Yun-Bo Shi; #93338) was raised against a multiple antigenic peptide corresponding to amino acids 104-123 of xTRβ. The antisera were tested at different dilutions to the optimize the signal to noise ratio. The xTRα antiserum was found to produce high background staining and to crossreact with xTRb by Western blotting (X. laevis TR bacterial expression vectors provided by Yun-Bo Shi) and thus was not used further (see below). The xTRβ antiserum was used at a final dilution of 1:4000 for IHC (discussed below).
Histochemistry
Tadpole heads were fixed in 4% paraformaldehyde in 0.01 M phosphate buffered saline (PBS) overnight at 4°C. Brains were removed from the skull and saturated with 30% sucrose in 0.01 M PBS at 4°C overnight, then embedded in Tissue-Tek Cryo-OCT compound (Fisher Scientific) or M1 embedding matrix (Shandon Lipshaw, Inc., Pittsburgh, PA) and frozen at −80°C. Twenty micron cryosections in either the sagittal of the transverse plane were made and stored at −80°C until processing for IHC or a combination of IHC and ISHH.
Immunostaining of mitotic cells
Newborn cells in the tadpole brain were detected by IHC for BrdU. Briefly, tissue sections were denatured with 2 N HCl at 37°C for 30 min, rinsed with TBS and blocked with 5% normal goat serum in TBS at room temperature (rt) for 15 min. Tissue sections were then incubated with anti-BrdU serum (1:500; generated in rat; Serotec Inc., NC) for 24 h at rt. We used anti-rat-FITC for fluorescent detection of primary anti-BrdU immune complexes.
Mitotic cells were detected using a rabbit antiserum raised against human pH3 (Upstate Biotechnology, NY). The amino terminus of this protein (serine 10) becomes phosphorylated during late G2 through M phase of the cell cycle and has been used to detect dividing cells in X. laevis (Saka and Smith, 2001; Schreiber et al., 2001 ). Brain sections were first incubated with the primary antibody at 1:500 overnight at 4°C. Primary immune complexes were detected using a secondary antibody conjugated with Cy3 (1:500, Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). Sections were counterstained with a fluorescent green nuclear stain (SYTO 13, Invitrogen, Carlsbad, CA).
In situ hybridization for TR mRNAs, and combined ISHH for TRα with IHC for BrdU
Linearized plasmid templates were prepared, and sense or antisense digoxigenin (DIG)-labeled TR probes were transcribed in vitro using a DIG RNA labeling kit (Boehringer-Mannheim). For ISHH, cryosections were incubated with 1 μg of sense or antisense probe overnight at 55°C. Tissue preparation, hybridization and rinsing followed standard protocols (Mansour et al., 1994) . A monoclonal mouse anti-DIG antibody (1:500; Roche) was used to detect RNA hybrids. Primary immune complexes were detected with a goat antimouse secondary antibody conjugated with Cy3. The specificities of the riboprobes were confirmed by the absence of signal with sense probes on consecutive sections, and by the absence of signal with antisense probes in premetamorphic tadpoles (for TRβ). For dual fluorescent immunodetection of TRα mRNA and BrdU brain sections were first processed for ISHH followed by IHC for BrdU as described above.
Dual fluorescent IHC for BrdU and TRβ protein
For double-labeling IHC, tadpole brain sections were first processed as described above for detection of BrdU. For detection of TRβ protein, the slides were rinsed in TBS, blocked with Superblock (Pierce Chemical Co.) plus 5% normal goat serum in TBS for 15 min at rt, and incubated overnight at 4°C with rabbit anti-TRβ serum (1:4000). We used anti-rabbit-Cy3 for fluorescent detection of primary anti-TRβ immune complexes. Stained sections were analyzed by confocal microscopy using a Zeiss laser scanning confocal microscope. Sections were scanned at 1 μm thickness using Z-stack to determine if TRα mRNA and BrdU, or TRβ protein and BrdU were colocalized.
To map TRβ immunoreactive (ir) cells throughout the tadpole brain we treated NF stage 52 tadpoles with T 3 (50 nM) for 48 h before sacrifice. Brains were fixed, cryosections prepared and sections were stained with anti-TRβ serum (1:4000) as described above, with the exception that we treated sections with 0.1% Triton X-100 before blocking. For detecting primary immune complexes we used the Vectastain elite ABC (rabbit) and Vector VIP kits (Vector Laboratories, Inc., Burlingame, CA, USA) following the manufacturer's instructions. We followed the anatomical definitions of Tuinhof et al. (1998) with modification of basal ganglia subdivisions according to Marín et al. (1998) ; see Yao et al. (2004) .
Electroporation-mediated gene transfer
Brains of living premetamorphic tadpoles (NF stage 52) were transfected with a X. laevis TRβ promoter-EGFP reporter plasmid (a gift of Dr. Ken Oofusa; Oofusa et al., 2001) following methods described by Haas et al. (2002) and Yao et al. (2007) . This plasmid contains the 5′ flanking region of the X. laevis TrβA gene (−1562 to +312) and has been used to generate transgenic animals by restriction enzyme-mediated insertional transgenesis; these animals express EGFP in a tissue-specific and T 3 -dependent manner (Oofusa et al., 2001) . Tadpoles were anesthetized in 0.002% benzocaine and given a single intracerebroventricular (i.c.v.) injection of 92 nl DNA solution (1 μg/μl; with 0.02% fastgreen dye) using a Drummond microinjector. We then positioned a pair of platinum electrodes over the skull and delivered five pulses of 30 V each. Tadpoles were allowed to recover overnight, then treated with T 3 (50 nM) for 48 h, and with BrdU (500 μM) for 3 h before sacrifice and subsequent harvest of brains for IHC. We conducted double labeling immunofluorescence histochemistry and analyzed sections by confocal microscopy as described above. We detected EGFP using a rabbit anti-GFP serum (1:5000; Torrey Pines Biolabs, Houston, TX) and goat anti-rabbit Cy 3 secondary.
Data analysis and statistics
Image analysis was conducted in a blinded manner. All sections were carefully matched for anatomical level, and digital micrographic images of immunostained slides were captured using a Nikon Eclipse E600 microscope (Nikon, Tokyo, Japan) and a Spot 10 CCD camera (Model 1.4.0; Diagnostic Instruments, Inc., Sterling Heights, MI), or an Olympus IX81 inverted microscope (Olympus, Tokyo, Japan) and a Retiga 1300R Fast digital video camera (QI Imaging, Tuscon, AZ). Images were analyzed in a blinded manner using Scion Image software (Scion Corp.) For BrdU, the total area of BrdU-ir in discrete regions of the tadpole brain was determined, and these values were compared by one-way ANOVA followed by a post-hoc analysis using Fisher's LSD test (α = 0.05). Cells staining positive for pH3 were manually counted and differences between treatments compared by one-way ANOVA. Data were log 10 transformed prior to ANOVA if the variances were found to be heterogeneous (Bartlett's test).
Results
T 3 promotes cell proliferation in neurogenic zones of the early prometamorphic tadpole brain by shortening the cell cycle Treatment of premetamorphic tadpoles (NF stage 52) with T 3 (50 nM for 48 h; BrdU present throughout) caused a large increase in BrdU labeled cells in the VZ/SVZ throughout the tadpole brain (Experiment 1; see Fig. 1 for experimental details; representative sagittal sections are shown in Fig. 2A ). The uptake of BrdU could be affected by T 3 treatment, so we used an independent method to analyze cell proliferation. Immunohistochemistry for pH3 confirmed the proliferative actions of T 3 , revealing a 4-fold increase over controls in the number of mitotic cells in the VZ/SVZ in brains of premetamorphic tadpoles treated with T 3 for 48 h (Figs. 2B,C) .
Using a 'pulse-chase' BrdU labeling protocol (Experiment 2; for experimental details see Fig. 1 ) we found that the increased cell proliferation in the VZ/SVZ caused by T 3 was due to a shortening of the cell cycle rather than the recruitment of more stem cells to proliferate. At 24 h after addition of T 3 there was no difference in BrdU labeling between control vs. T 3 -treated tadpoles (Fig. 2D, panels 1, 2) . However, after 48 h of T 3 treatment we observed a dramatic increase in the number of BrdU immunoreactive (-ir) cells compared to controls, which exhibited more diffuse staining owing to the dilution of the BrdU by cell division (Fig. 2D, panels 3,4) . Many BrdU-ir cells exhibited elongate nuclei, which suggests that these newborn cells were migrating out of the proliferative zone. The diffuse staining pattern of BrdU-ir in the brain following 48 h T 3 treatment was not observed in the pituitary gland, which showed intense BrdU staining that was unaffected by T 3 treatment (data not shown).
Developmental stage-dependent cell proliferation in the tadpole brain
We analyzed cell proliferation in the VZ/SVZ of the tadpole brain during spontaneous metamorphosis or following T 3 treatment at different developmental stages (Fig. 3) . During premetamorphosis (NF stage 52-53) the rate of cell proliferation was low, rose slightly between stages 52-53 and 54-55, then exhibited a dramatic increase (∼ 4-fold) between stages 54-55 and 56-57 (prometamorphosis). The rate of proliferation remained elevated during late prometamorphosis (stage 58-59) and the beginning of metamorphic climax (stage 60-61) but dropped significantly at the height of metamorphic climax (stage 62-63).
During premetamorphosis and early prometamorphosis the numbers of proliferating cells were similar across different brain regions (NF stages 52-55; Table 1 ). It is unlikely that the rate of cell proliferation during this stage of development is entirely dependent on endogenous thyroid hormone since mitosis proceeds in hypophysectomized tadpoles (Race, 1961) . Mitosis increased dramatically thereafter, and the largest number of proliferating cells was observed in the optic tectum at stage 56-57. The rate of proliferation in the tectum dropped off precipitously thereafter; whereas, in other brain regions the decline was slower and extended through metamorphic climax (Table 1 ). Our analysis is in agreement with a description by Filoni et al. (1995) in X. laevis tadpoles who reported that the most dramatic decline in mitotic index through metamorphosis occurred in the mesencephalon (containing the optic tectum); the decline was slower in the cerebellum, and slowest in the telencephalon.
Treatment of tadpoles with T 3 (50 nM) during premetamorphosis and early prometamorphosis dramatically increased cell proliferation in the VZ/SVZ throughout the brain, as measured by staining for both pH3 and BrdU (Figs. 3A,B; data for pH3 not shown). By NF stage 56-57 when cell proliferation was maximal tadpoles became refractory to T 3 treatment, which persisted through metamorphic climax. The decline (D) T 3 shortens cell cycle time in early prometamorphic tadpole brain. Tadpoles were treated as described for Experiment 2. Transverse brain sections were stained for BrdU. There were no differences in BrdU-ir between brains from control (panel 1) or T 3 treated (panel 2) animals 24 h after treatment. However, after 48 h there was a significant increase in the number of BrdU-ir cells in brains of T 3 -treated animals (panel 4) compared to controls (panel 3). T3-treated animals exhibited more diffuse staining owing to the dilution of the BrdU by cell division. Many BrdU-ir cells seen in panel 4 exhibited elongate nuclei, suggesting that the newborn cells were migrating out of the proliferative zone. Scale bar =50 μm.
in cell proliferation at metamorphic climax (NF stage 62-63) could not be rescued by T 3 treatment.
To test whether the high rate of cell proliferation during prometamorphosis depends on endogenous thyroid hormone we treated NF stage 56 tadpoles with the goitrogen MMI (Experiment 4; see Fig 1 for details) . MMI treatment caused a significant decrease in the number of BrdU positive cells throughout the tadpole brain, which was rescued by treatment with T 3 (Fig. 4) .
Distribution of TRα and TRβ, and location of neurogenic zones in the tadpole brain
Neurogenic zones, as identified based on the distribution of BrDU-ir and pH3-ir, occur in all periventricular regions throughout the tadpole brain as indicated in Fig. 5 (see also Schreiber et al., 2001; Wullimann et al., 2005) . In situ hybridization histochemistry for TRα mRNA showed that this transcript is widely and highly expressed in the tadpole brain as has been reported previously (Kawahara et al., 1991) . TRα mRNA was expressed in virtually all cells in the brain, and we found no significant effect of T 3 treatment on TRα expression, nor did we observe any signal on sections hybridized with sense probe (data not shown). We were unable to conduct IHC for TRα as the currently available antisera for Xenopus TRα exhibited high nonspecific activity and crossreaction with TRβ (see Fig. 6A ).
We detected expression of TRβ mRNA in the tadpole brain only after treatment with T 3 , but the signal was too low to accurately document. This is consistent with the very low TRβ signal (compared to TRα) reported by Kawahara et al. (1991) in X. laevis tadpole brain. By contrast, while TRβ immunoreactivity (TRβ-ir; analyzed by IHC) in premetamorphic tadpole brain was low, it increased dramatically following T 3 treatment which allowed us to map its expression throughout the tadpole brain (Figs. 5, 6B ). We observed discrete groups of TRβ-ir cells in the telencephalon, diencephalon, mesencephalon, and rhombencephalon. The TRβ-ir was restricted to the cell nuclei, and occurred predominantly outside of the neurogenic zones lining the ventricles (see Fig. 6B ). A schematic representation of the distribution of TRβ-ir cells in the tadpole brain and pituitary gland is shown in Fig. 5 and representative immunostained sections are shown in Fig. 6B .
In the telencephalon (Fig. 5 , panels A-C), the most rostral sites of TRβ-ir were seen in the lateral pallium within the olfactory bulbs. In the caudal telencephalon, strongly stained TRβ-ir cells were localized in the dorsal, lateral and medial pallium, striatum, lateral septum and nucleus accumbens (see Fig. 6B, panels 1,2) . In the rostral telencephalon (Fig. 5 , panels D-H) TRβ-ir cells were observed in the lateral, medial, and central amygdala (see Fig. 6B, panel 3) . TRβ-ir cells were localized in both the parvocellular (Fig. 6B, panel 4) and the magnocellular divisions of the anterior preoptic area (site of hypophysiotropic neurosecretory neurons in the frog brain), and in the diencephalon, in the hypothalamus (Fig. 6B, panel 5 ) thalamus, Tadpoles were treated with BrdU as described for Experiment 3 (see Fig. 1 ). Immunohistochemistry was conducted for BrdU or pH3 as described in Materials and methods. Developmental staging is Nieuwkoop and Faber (Nieuwkoop and Faber, 1994) . The plus signs indicate relative numbers of BrdU or pH3 positive cells observed throughout the tadpole brain compared to the maximum level seen in the optic tectum at stage 56-57. The minus signs indicate no BrdU or pH3 positive cells were observed.
Fig. 3. (A) Profiles of brain cell proliferation during spontaneous metamorphosis and
following T 3 treatment, measured by the number of BrdU-positive cells. Tadpoles were treated as described for Experiment 3 (see Fig. 1 ). During spontaneous metamorphosis (Control) cell proliferation was low at premetamorphic (Premet) stages, peaked during prometamorphosis (Promet; NF stage 56-57) and declined at metamorphic climax (Climax; NF stage 62-63). T 3 treatment significantly increased cell proliferation at premetamorphic and early prometamorphic stages but failed to alter cell proliferation at later stages. (B) Developmental changes in BrdU labeling in the tadpole optic tectum. There were numerous BrdU-ir cells at prometamorphosis (NF stage 56; b); whereas, there were few BrdU-ir cells in premetamorphic (NF stage 52; a) or late prometamorphic (NF stage 62; c) brains. tect, optic tectum; V, ventricle. Scale bar = 50 μm. Fig. 4 . Blockade of endogenous thyroid hormone synthesis by the goitrogen methimazole reduces cell proliferation in tadpole brain. Tadpoles were treated as described for Experiment 4 (see Fig. 1 ). Prometamorphic tadpoles (NF stage 56) were treated with or without methimazole (MMI; 1 mM) for 1 week. A subset of animals received T 3 (10 nM) for the final 2 days of the treatment period. MMI treatment reduced brain cell proliferation, as measured by pH3 staining. Addition of exogenous T 3 to the MMI-treated tadpoles restored the rate of proliferation to a level comparable to that of controls.
Fig. 5. (A-L) Schematic coronal illustration of neurogenic zones (gray bands surrounding ventricles on left of sections; identified by the distribution of BrDU and pH3
immunoreactivity) and thyroid hormone receptor β (TRβ) immunoreactivity (-ir; large and small dots on right of sections) distribution in the brain of NF stage 52 X. laevis tadpoles following 48 h treatment with T 3 (50 nM). TRα mRNA, which is not shown in the figure, is highly expressed in all neurogenic zones and many other areas throughout the tadpole brain. The drawing at the top of the figure shows a dorsal view of the X. laevis brain. Letters correspond to the rostrocaudal location of sections as depicted in the whole-brain drawing. Large circles represent large cells that exhibited robust TRβ-ir, and small circles represent smaller TRβ-ir cells. The anatomical drawings are from Tuinhof et al. (1998) , with modifications of basal ganglia subdivisions according to (Marín et al., 1998) . Abbreviations are defined in Table 2. posterior tuberculum and in the suprachiasmatic nucleus. In the mesencephalon (Fig. 5 , panels I-J) we observed strong TRβ-ir cells in different layers of the optic tectum (Fig. 6B, panel 6 ), the torus semicircularis, and tegmental nuclei. In the rhombencephalon (Fig. 5 , panels K-L) TRβ-ir was observed in the cerebellum, and small, weakly stained TRβ-ir cells were seen in the raphe nuclei, reticular nuclei, and nuclei of the trigeminal motor nerves. In the pituitary gland strong TRβ-ir was found distributed throughout the pars distalis and the pars intermedia.
TRα but not TRβ is expressed in proliferating cells in the tadpole brain
Dual labeling for TRα mRNA and BrdU revealed that all BrdU-ir cells express TRα ( Fig. 7A ; only the hypothalamus and cerebellum are shown, and identical results were obtained in other brain areas). The T 3 treatment/BrdU labeling protocol used was that described for Experiment 3 (see Fig. 1 for details) where BrdU was given for a brief, 3 h period at the end of 48 h of T 3 treatment. Therefore, cells that are actively proliferating express TRα mRNA. The strongest staining for TRα mRNA was seen in BrdU-positive cells, but not all cells that expressed TRα mRNA were BrdU positive.
Using double immunofluorescence labeling and confocal microscopy we found that the majority of BrdU-ir cells were negative for TRβ protein ( Fig. 7B ; representative sagittal sections through the region of the thalamus and optic tectum are shown, and identical results were obtained in other brain areas; protocol Experiment 3; see Fig. 1 ). The TRβ-ir was seen predominantly outside of the VZ/SVZ (see also Fig. 6B ), and while we observed some TRβ-ir in parts of the VZ/SVZ, these areas were not undergoing active neurogenesis in response to T 3 .
Transfection of tadpole brain in vivo with a TRβ promoter-EGFP plasmid showed that the majority of EGFP expressing cells were not dividing
To corroborate the TRβ expression pattern that we observed by IHC, we used electroporation-mediated gene transfer to transfect the brains of living premetamorphic tadpoles with a vector containing the frog proximal TrβA promoter driving EGFP (Oofusa et al., 2001) . Plasmid DNA was injected into the region of the third ventricle and electrical current was applied. EGFP fluorescence was very low in untreated tadpole brain but was increased strongly by treatment with T 3 as has been reported previously (Oofusa et al., 2001) . Similarly, the rate of cell proliferation as assessed by BrdU labeling was low in untreated tadpole brain; therefore, only brain sections from tadpoles treated with T 3 were analyzed by confocal microscopy and are shown in Fig. 8 . We observed 94% of EGFP expressing cells at the periphery or within the SVZ. We found a few EGFP-positive cells more distal to the SVZ, which was limited by the transfection efficiency as the distance from the ventricular surface increased. Only 6% of EGFP positive cells were seen within the VZ (n = 12; Fig. 8, panels 1, 2) . Confocal microscopy confirmed that the majority of EGFP expressing cells (74%) were not labeled with BrdU, and these cells possessed short or no visible processes (Fig. 8, panels 1, 2) . Of the cells in which EGFP and BrdU were colocalized (26%) most had the morphology of radial glia, with long processes that terminated in endfeet at the pial and ventricular surfaces (Fig. 8, panels 3, 4) .
TRα-selective, but not TRβ-selective ligands induce cell proliferation in the tadpole brain
As we found earlier, treatment with T 3 for 48 h caused a large increase in cell proliferation in the VZ/SVZ throughout the tadpole brain. However, the TRβ selective ligands GC1 or GC24 did not alter brain cell proliferation, while the TRα selective ligand CO23 increased brain cell proliferation similar to the T 3 treated group (F (4,15) = 6.734, P = 0.003; ANOVA; Fig. 9A ). We confirmed the potencies of the GC analogs in vivo by treating tadpoles for 6 days with GC1 or GC24 and observed morphological changes similar to those reported previously by Furlow et al. (2004) ; GC1 and GC24 caused the digits to differentiate and the gills to resorb; Fig. 9B ).
Discussion
Cell proliferation in ventricular and subventricular zones throughout the tadpole brain increased dramatically as the animals entered metamorphosis, which correlates with the rise in plasma T 3 concentration at this time. Mitosis can be induced precociously by the addition of T 3 to the aquarium water of premetamorphic tadpoles. Conversely, cell proliferation in the prometamorphic tadpole brain was reduced to premetamorphic levels by blocking the endogenous rise in plasma T 3 . We provide evidence that the action of T 3 on neurogenesis is mediated by the alpha subtype of the thyroid hormone receptor, and may be cell autonomous. We found TRα to be highly expressed in the VZ/SVZ of the X. laevis tadpole brain, regions of active neurogenesis; whereas, TRβ was expressed predominantly outside of neurogenic zones where cells undergo migration and differentiation. The induction of brain cell proliferation by the TRα selective agonist CO23, but the failure of TRβ selective ligands to induce cell proliferation at concentrations that preferentially activate TRβ support the view that the TRα mediates the hormone response.
Patterns and rates of cell proliferation in the tadpole brain
Earlier studies of mitosis in the tadpole nervous system, and the effects of exogenous thyroid hormone were summarized by Jacobson (1991) . In agreement with these studies, we found that mitotic activity was restricted to the VZ/SVZ throughout the tadpole brain. This activity increased dramatically during early prometamorphosis, which is coincident with the rise in endogenous thyroid hormone production (Krain and Denver, 2004; Leloup and Buscaglia, 1977; Tata, 1993) . The mitotic activity reached a peak at mid-prometamorphosis, then declined through late-prometamorphosis and climax. We observed brain regional differences in the magnitude of mitotic activity at the peak (NF stage 56-57), with the optic tectum exhibiting the highest mitotic index. Cell proliferation in the optic tectum dropped off precipitously by stage 58 and was absent thereafter; whereas, cell proliferation continued in the telencephalon, diencephalon and cerebellum through metamorphic climax (see Table 1 , Fig. 3 ).
The rate of cell proliferation in the early prometamorphic tadpole brain was low, but could be increased dramatically by treatment with exogenous T 3 . We also found that treatment with the goitrogen MMI decreased mitosis in prometamorphic animals to levels seen in the premetamorphic tadpole brain, and that this could be reversed by T 3 treatment. These findings show that the increase in the rate of cell proliferation that occurs during prometamorphosis depends upon the endogenous rise in thyroid hormone production. Reynolds (1966) reported that treatment with thiourea decreased cell proliferation in the lumbosacral spinal cord of Rana pipiens tadpoles. However, Reynolds did not conduct a rescue/replacement experiment to rule out the possibility of a nonspecific, or neurotoxic effect of the chemical. Here we show that the decrease caused by the goitrogen could be rescued by replacement with T 3 .
Our 'pulse-chase' experiment showed that T 3 stimulated cell proliferation by shortening cell cycling time rather than by recruiting more stem cells to proliferate. This is consistent with findings in rat pituitary GH producing GC cells which proliferate in response to T 3 by shortening G1 phase (Barrera-Hernandez et al., 1999) . These investigators also showed that T 3 increased expression of cyclins D1 and E, and cdk2, and increased phosphorylation of retinoblastoma protein which is responsible for driving G1 to S cell cycle progression. The increased mitosis with exogenous thyroid hormone does not appear to lead to an increase in the final size of the tadpole brain Fig. 6 . (A) Western blots testing the specificity of antisera raised against synthetic peptides corresponding to xTRα (top gel; 1:1000) and xTRβ (bottom gel; 1:1000). Polyacrylamide gels (10 %) were loaded with lysates of bacteria expressing xTRα (lanes 1,2,3: 5, 2.5, 1.25 μl induced lysate; lane 4, 5 μl uninduced lysate) or xTRβ (lanes 5,6,7: 5, 2.5, 1.25 μl induced lysate; lane 8, 5 μl uninduced lysate). Note that the anti-xTRα serum crossreacts with xTRβ (arrows showing two immunoreactive bands in both lysates) and was not used for further study; whereas, the anti-xTRβ serum was specific for xTRβ and was used for IHC. (B) Representative photomicrographs of transverse sections through the brain of a NF stage 52 tadpole that had been treated with T 3 (50 nM) for 48 h showing the distribution of TRβ immunoreactive (TRβ-ir) cells. 1. Dorsal pallium (dp), medial pallium (mp) and lateral pallium (lp), and internal granule cell layer (igl; Fig. 5, panel B) . 2. Dorsal, medial and lateral pallium, striatum (Str) and accumbens (Acc; Fig. 5, panel C) . 3. Dorsal, medial and lateral pallium, lateral amygdala (LA), medial amygdala (MeA) and central amygdala (CeA; Fig. 5, panel D) . 4. Anterior preoptic area (Fig. 5, panel D) . 5. Ventral hypothalamic area (Fig. 5, panel G) . 6. Optic tectum (Fig. 5, panel J) . Scale bar = 200 μm. (Baffoni, 1957) . However, thyroid hormone appears to be necessary to achieve normal brain size in amphibians. For example, although thyroidectomized tadpoles reach a giant body size their brains are smaller than controls (Allen, 1924) . A similar situation is seen in the rat (reviewed by Anderson et al., 2003) . By NF stage 56-57 when the spontaneous rate of cell proliferation is highest, tadpoles become refractory to exogenous T 3 . This suggests that while exogenous thyroid hormone can induce precocious cell proliferation, it does not lead to the production of more cells; i.e., there is a finite precursor pool with a finite number of possible cell divisions.
We found that exogenous T 3 could not rescue the decline in proliferation that occurs at metamorphic climax. Cai and Brown (2004) proposed that the expression of deiodinase type II (D2), which converts T 4 to T 3 , is necessary for the actions of T 4 on brain cell proliferation, and the decline in D2 expression in the tadpole VZ/SVZ may be causally related to the cessation of cell proliferation in the tadpole brain. However, this implies that while the cells may not respond to T 4 , they should still be responsive to T 3 , but they are not. Earlier we showed that a 50 nM dose of T 3 produces tissue concentrations of ∼ 480 nM by 24 h of treatment (i.e. the hormone is actively taken up and concentrated from the medium), which contrasts with a peak of ∼ 18 nM T 3 tissue concentration at metamorphic climax (Krain and Denver, 2004) . If the cells could respond to T 3 by proliferating, then the dose of hormone should have been more than sufficient. Therefore, the decrease in D2 may be correlated with a terminal differentiation event, but it is probably not responsible for the lack of thyroid hormone action on brain cell proliferation in late prometamorphic and climax stage tadpoles.
Expression and roles of TR subtypes in neurogenesis in the tadpole brain
Several investigators have analyzed the expression of TRs in tadpoles during metamorphosis. In X. laevis TRα expression increases shortly after hatching and is maintained at a high level throughout metamorphosis, declining after climax (reviewed by Shi, 2000) . TRα transcripts are detectable in all tadpole cells that have been examined, and the highest expression is seen in cells that proliferate upon treatment with T 3 ; e.g, the limb buds, basal layers of the skin, specific head cartilages and SZ/SVZ zones of the brain (Berry et al., 1998a) . During early prometamorphosis when plasma thyroid hormone concentrations are low but starting to rise, cell proliferation increases Fig. 1 ). Dual labeling histochemistry was conducted for TRα mRNA (red; by ISHH) and BrdU (green; by IHC) on sagittal sections of T 3 -treated tadpole brain (regions shown are the diencephalon and cerebellum). Sections were analyzed by confocal microscopy. Note the colocalization of TRα mRNA and BrdU-ir in cords of cells adjacent to the ventricles. Hypo, hypothalamus; Pit, pituitary. Scale bar = 50 μm. (B) Treatment with T 3 increases TRβ immunoreactivity (ir) in tadpole brain, and TRβ is excluded from the majority of BrdU-positive cells. Premetamorphic tadpoles (NF stage 52) were treated as described for Experiment 3 (see Fig. 1 ). Dual fluorescent immunohistochemistry was conducted for BrdU (green) and TRβ (red) without (1-3) or with (4-6) T 3 treatment. Sections were analyzed by confocal microscopy. Shown is the region of the thalamus and optic tectum in the sagittal plane. In untreated tadpoles few BrdU-ir or TR-ir cells are detected (1 -TRβ, 2 -BrdU, 3 -merge), but T 3 treatment significantly increased TRβ-ir (4 -TRβ) and cell proliferation (5 -BrdU). Only a small proportion of BrdU-ir cells express TRβ, as indicated by the yellow cells (6 -merge). Scale bar = 50 μm.
in the limb buds and in cells of the SV/SVZ of the brain (see Fig. 3 ), and both have high constitutive levels of TRα mRNA (see Fig. 7A ; Furlow and Neff, 2006; Schreiber et al., 2001) . By contrast, TRβ mRNA expression is low or nondetectable during embryogenesis and premetamorphosis, but then is strongly induced during prometamorphosis coincident with rising plasma T 3 concentrations (Krain and Denver, 2004; . During prometamorphosis TRβ is highly expressed in resorbing tissues such as the tail, and in the brain, which at this time undergoes extensive cell migration and neuronal differentiation/maturation (Denver, 1998) , but at relatively low levels in most proliferating tissues (Berry et al., 1998a; Furlow and Neff, 2006) . TRβ mRNA expression peaks at metamorphic climax (NF stage 60; Krain and Denver, 2004; when the rate of cell proliferation is declining (see Fig. 3 ). Levels of TRα protein were estimated to be 2-3 times greater than TRβ in the head and tail of premetamorphic tadpoles and did not change significantly throughout metamorphosis, while TRβ protein increased strongly through metamorphic climax (Eliceiri and Brown, 1994) . These expression patterns, and other lines of evidence have led to the hypothesis that the two TR subtypes serve different developmental roles. The early expression of TRα establishes tissue competence to respond to T 3 , thus supporting the early proliferative actions of the hormone (Furlow and Neff, 2006; Tata, 2006) , and prior to the production of T 3 , the aporeceptor may repress gene expression (dual-function model; see Buchholz et al., 2006) . Whereas, the upregulation of TRβ in response to T 3 functions in tissue remodeling and organogenesis through regulation of apoptosis and cell differentiation (Furlow and Neff, 2006; Tata, 2006) . Kawahara et al. (1991) conducted a rough analysis of TRα and TRβ mRNA expression in the tadpole by ISHH and reported that TRα was widely and highly expressed compared with TRβ, which was only induced by T 3 at metamorphosis and exhibited a restricted expression pattern within tissues. Using ISHH we also found TRα expression throughout the tadpole brain, which is consistent with widespread expression of TRα transcripts (TRα1 and TRα2) in mammalian brain (Bradley et al., 1992) . Similar, to the findings of Kawahara et al. (1991) we found that TRβ expression in premetamorphic tadpole brain was very low, but increased dramatically in several brain areas following treatment with T 3 . We found strongest TRβ-ir outside of neurogenic zones in the tadpole brain (see Fig. 6B ). Furthermore, EGFP expression driven by the xTRβ promoter in transfected tadpole brain was observed predominantly in cells that were not proliferating. The TRβ expression pattern, as evidenced by two independent methods, is consistent with a lack of involvement of TRβ in brain cell proliferation. While the majority of TRβ-ir was outside of the VZ/ SVZ, there was some TRβ staining in parts of the VZ/SVZ that were not undergoing active neurogenesis following treatment with T 3 . Berry et al. (1998b) reported both TRα and TRβ mRNA expression by ISHH in the ventricular region of the tail spinal cord but did not analyze their expression specifically in mitotic cells.
We observed strong expression of EGFP driven by the xTRβ promoter in radial glia, which extended long processes from the SVZ to the pial and ventricular surfaces, and most of these cells were also BrdU positive. During mitosis the long processes of radial glia cells remain attached to the pial and ventricular surfaces (Miyata et al., 2001; Noctor et al., 2001 ). These cells divide asymmetrically to produce self-renewing radial glial cells and post-mitotic neuronal daughter cells with each round of cell division (Götz and Huttner, 2005) . The strong EGFP expression in these cells driven by the xTRβ promoter is consistent with TRβ being expressed in cells that display a differentiated phenotype (i.e., long processes). It also suggests that, while TRβ may not promote cell proliferation, it also may not antagonize entry into or progression through the cell cycle (contrary to what has been found in the mouse neuronal cell line Neuro-2a; Lebel et al., 1994) . It is possible that the expression of TRβ turns off as the radial glial cells progress through the cell cycle. In our experiments the tadpoles were pulsed with BrdU 3 h before sacrifice, and so all of the BrdU-labeled nuclei represented cells that were born within that 3 h period. It would be interesting to examine whether in the following hours, as the cell progresses through the cell cycle, the TRβ promoter is turned off and then on again in the radial glial cell, and on in the post-mitotic neuronal daughter cell.
The induction of cell proliferation by the TRα-selective agonist CO23, but the failure of the TRβ selective agonists GC1 and GC24 to affect proliferation is consistent with the TRα mediating proliferative actions of T 3 . Evidence for the TRα selectivity of CO23 in X. laevis in vivo is supported by the finding that it caused significant hindlimb growth with roughly equal potency to T 3 , but was much less potent in affecting tail and gill resorption, or cranial restructuring (Ocasio and Scanlan, 2006) . Growth of the hindlimbs is one of the earliest observable thyroid hormone-dependent changes and is thought to be dependent on TRα since this receptor subtype is highly expressed in this tissue, while the expression of TRβ is low and restricted to the area of the digits (Buckbinder and Brown, 1992; Fairclough and Tata, 1997) ; whereas, tissue resorption and differentiation (including the digits of the limbs) occurs later upon autoinduction of TRβ (Furlow and Neff, 2006) . While we did not analyze specific roles for TRβ in the current study, it is noteworthy that the TRβ-specific analogs caused differentiation of the hindlimb digits and gill resorption, but not cell proliferation in the brain. In both amphibians and mammals the expression of TRβ correlates closely with T 3 -dependent morphogenesis (Furlow and Neff, 2006; Nunez et al., 2008) , and findings support the hypothesis that TRβ controls cell differentiation and apoptosis but not neural cell proliferation (Lebel et al., 1994; Perez-Juste and Aranda, 1999) . Although GC1 binds preferentially to TRβ, it can also interact with TRα, albeit with 4-10-fold lower affinity (Baxter et al., 2004; Chiellini et al., 1998) . By contrast, GC24 had 10-fold greater selectivity for TRβ vs. TRα compared with GC1 based on binding affinity, and thus is a more selective ligand for TRβ (Borngraeber et al., 2003) . Further support for TRα mediating cell proliferation, and TRβ mediating tissue resorption and cell differentiation, was provided by sequential treatment of tadpoles with CO23 then GC1, or GC1 then CO23 (Ocasio and Scanlan, 2006) .
Findings from other laboratories support the view that TRα mediates the proliferative actions of T 3 on neuroblasts. For example, Lezoualch et al. (1995) transfected embryonic chick optic lobe with antisense oligonucleotides (ODNs) directed against TRα and found a significant decrease in [ 3 H]thymidine incorporation; whereas, antisense ODNs to TRβ had no effect. The efficacy of the knockdown of both TRα and TRβ by the respective antisense ODNs was confirmed by the loss of T 3 -activated reporter activity in transfected tissues. Lemkine et al. (2005) concluded that liganded TRα is essential for neurogenesis in adult mammal brain. They showed, using TR subtype specific knockout mice, that TRα but not TRβ is essential for T 3 -dependent adult neural stem cell proliferation. Morte et al. (2002) found that, by contrast to the effects of T 3 , treatment with the TRβ-specific analog GC1 did not promote cerebellar granule cell migration but partially enhanced Purkinje cell maturation in mouse. Taken together with their analysis of the TRα1 knockout mouse, they concluded that granule cell migration (and perhaps proliferation) is under the control of TRα1, while Purkinje cell maturation may be mediated by TRβ (see also Hashimoto et al., 2001) . Schlosser et al. (2002) found an increase in the number of xNeuroD positive cells (i.e., neurons) in the spinal cord of early stage Xenopus tadpoles with T 3 (NF stage 35/36), a stage at which TRα, but not TRβ is expressed. They also showed that injecting mRNAs for xTRα plus RXR into Xenopus embryos increased neurogenic responses to T 3 in the spinal cord, but repressed neurogenesis in the absence of hormone. Other cell types have been shown to require TRα for proliferation in mouse (e.g., Sertoli cells: Holsberger et al., 2005; erythroblasts: AngelinDuclos et al., 2005) .
In summary, our findings show that the increase in proliferation in the tadpole brain during metamorphosis depends on the rise in endogenous T 3 production. The magnitude of mitotic activity varies with brain region, being highest in the optic tectum, where it drops off precipitously after stage 58, but continues in other brain areas through metamorphic climax. Expression analysis of TRα and TRβ, and studies with TRα and TRβ selective ligands support the hypothesis that the action of thyroid hormone on neurogenesis in the tadpole brain may be cell autonomous, and is mediated by the alpha subtype of the thyroid hormone receptor. Fig. 9 . The TRα selective agonist CO23, but not the TRβ selective agonists GC1 and GC24, increases cell proliferation in the premetamorphic tadpole brain. (A) Quantification of the number of pH3-positive nuclei in the region of the lateral ventricles in tadpoles treated with vehicle (DMSO; control), T 3 (10 nM), GC1 (100 nM), GC24 (100 nM) or CO23 (100 nM) for 48 h. Compounds were added to the aquarium water and were replenished after 24 h. The length of both lateral ventricles from each animal was analyzed. Shown are the data from one of two experiments that gave identical results. (P b 0.05; ANOVA; n = 4/treatment). (B) The GC compounds caused external metamorphic changes, thus showing that they had biological activity. Shown are representative tadpoles treated with vehicle (DMSO; control), GC1 or GC24 (100 nM each) for 6 days (all of the T 3 treated tadpoles had died by 4 days and thus are not shown; CO23 animals were not analyzed -the effects on brain cell proliferation verified the biological activity of the CO23). The arrows point to the gills, which showed resorption following treatment with GC1 and GC24. Differentiation of the hindlimb digits was observed with both GC1 and GC24 treatment but not in controls (n = 6/treatment).
